News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–8
Matches
8
Sources here
5
Companies here
1
Search results Stored financial headlines

Active search

8 matching headlines

Ticker or company: 9926Main company stories
Clear
Latest

finance.yahoo.com Regulatory and legal

Akeso (SEHK:9926) Wins China Lung Cancer Approval As Breast Cancer Trial Begins

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Akeso (SEHK:9926) secured regulatory approval in China for ivonescimab plus chemotherapy as a first-line treatment for advanced squamous non-small cell lung cancer. The ivonescimab combination regimen is positioned as a new standard of care for advanced squamous …

Akeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer

HONG KONG, Aug. 10, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase II clinical study (AK146D1-202) evaluating AK146D1, the Company's internally developed TROP2/Nectin-4 bispecific antibody-drug conjugate (bsADC), in combination with ivonescimab …

9926 main company
Sharemaestro market context Price below Trend Line 52 weeks -45.7% · Next-week setup positive 58.6% 9926 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context